Image_2_NonO Is a Novel Co-factor of PRDM1 and Regulates Inflammatory Response in Monocyte Derived-Dendritic Cells.TIFF
Proper expression of the transcription factor, Positive regulatory domain 1 (PRDM1), is required for maintaining homeostasis of human monocyte derived-dendritic cells (MO-DCs). The molecular mechanisms and gene targets of PRDM1 in B and T lymphocytes have been identified. However, the function of PRDM1 in dendritic cells (DCs) remains unclear. We investigate co-regulators of PRDM1 in MO-DCs identified by mass spectrometry (MS) and co-immunoprecipitation (Co-IP). Notably, non-POU domain-containing octamer-binding protein (NonO) was found to be a PRDM1 binding protein in the nucleus of MO-DCs. NonO is recruited to the PRDM1 binding site in the promoter region of IL-6. Knockdown of NonO expression by siRNA lessened suppression of IL-6 promoter activity by PRMD1 following LPS stimulation. While NonO binding to PRDM1 was observed in human myeloma cell lines, an effect of NonO on IL-6 expression was not observed. Thus, loss of NonO interrupted the inhibitory effect of PRDM1 on IL-6 expression in MO-DCs, but not plasma cells. Moreover, MO-DCs with low expression of PRDM1 or NonO induce an increased number of IL-21-producing TFH-like cells in vitro. These data suggest that low level of PRDM1 and NonO lead to enhanced activation of MO-DCs and the regulation of MO-DC function by PRDM1 is mediated through cell lineage-specific mechanisms.
History
References
- https://doi.org//10.1101/gad.5.5.868
- https://doi.org//10.1128/MCB.12.5.1940
- https://doi.org//10.4049/jimmunol.178.7.4104
- https://doi.org//10.1016/S0925-4773(02)00189-2
- https://doi.org//10.1242/dev.012047
- https://doi.org//10.4049/jimmunol.165.10.5462
- https://doi.org//10.1016/S1074-7613(02)00335-7
- https://doi.org//10.1016/S1074-7613(03)00267-X
- https://doi.org//10.1016/0092-8674(94)90321-2
- https://doi.org//10.1136/ard.2010.140111
- https://doi.org//10.1084/jem.20110658
- https://doi.org//10.1074/jbc.M110.165431
- https://doi.org//10.1038/82788
- https://doi.org//10.1038/ni.3793
- https://doi.org//10.1016/j.immuni.2017.08.016
- https://doi.org//10.1128/MCB.20.7.2592-2603.2000
- https://doi.org//10.1128/MCB.01158-08
- https://doi.org//10.1038/ncb1413
- https://doi.org//10.1101/gad.13.1.125
- https://doi.org//10.4049/jimmunol.1600941
- https://doi.org//10.1038/ni1320
- https://doi.org//10.1038/ni1321
- https://doi.org//10.1016/j.cell.2010.09.039
- https://doi.org//10.1172/jci.insight.89569
- https://doi.org//10.20944/preprints201811.0508.v1
- https://doi.org//10.1038/ni.3349
- https://doi.org//10.1038/nbt0502-473
- https://doi.org//10.1038/nmeth947
- https://doi.org//10.2119/molmed.2014.00231
- https://doi.org//10.1007/s10059-013-2273-1
- https://doi.org//10.1093/hmg/ddt609
- https://doi.org//10.1161/ATVBAHA.107.144881
- https://doi.org//10.4049/jimmunol.0801692
- https://doi.org//10.1084/jem.20141380
- https://doi.org//10.4049/jimmunol.0901543
- https://doi.org//10.1038/77861
- https://doi.org//10.1084/jem.20160417
- https://doi.org//10.1038/icb.2012.17
- https://doi.org//10.7554/eLife.01949
- https://doi.org//10.1093/nar/gkaa213
- https://doi.org//10.1074/jbc.271.19.11177
- https://doi.org//10.1084/jem.20140425
- https://doi.org//10.1046/j.1365-2141.2002.03271.x
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity